Paper - WANFANG MED ONLINE

You Position: Home > Paper

炎症性肠病合并胰腺病变的研究进展

( views:188, downloads:426 )

Author:: No author available

Journal Title:: Chinese Journal of Pancreatology

Issue:: 4

DOI:: 10.3760/cma.j.issn.1674-1935.2019.04.020

Key Word:: 炎症性肠病;溃疡性结肠炎;克罗恩病;肠外表现;胰腺疾病

Abstract：炎症性肠病(IBD)包括克罗恩病和溃疡性结肠炎,是一组病因尚不明确的肠道疾病,其病变不仅累及肠道,还可出现肠外表现.与普通人群相比,IBD的胰腺疾病发病率升高,可并发急性胰腺炎、慢性胰腺炎、自身免疫性胰腺炎、胰腺外分泌功能不全以及实验室胰酶异常等,早期识别及治疗有利于IBD的诊治并提高患者的生活质量.

Reference

[1]沈祥国,邹多武,李兆申,等.炎症性肠病合并胰腺病变单中心分析[J].2018,(3).
[2]Sherman, Picardo,Kenji, So,Kannan, Venugopal,etc.Vedolizumab-induced acute pancreatitis: the first reported clinical case.[J].2018,2018(Spec ).
[3]van Geenen EJ,de Boer NK,Stassen P,etc.Azathioprine or mercaptopurine-induced acute pancreatitis is not a disease-specific phenomenon.[J].2010,31(12).
[4]R F, Logan,T P, van Staa.Sulphasalazine and mesalazine: serious adverse reactions re-evaluated on the basis of suspected adverse reaction reports to the Committee on Safety of Medicines.[J].2003,52(10).
[5]Ramos, Lidia Roque,DiMaio, Christopher J.,Sachar, David B.,etc.Autoimmune pancreatitis and inflammatory bowel disease: Case series and review of the literature[J].2016,48(8).
[6]Niels, Teich,Bernd, Bokemeyer,Wolfgang, Mohl,etc.Blood group B is associated with azathioprine-induced acute pancreatitis in patients with IBD.[J].2017,66(8).
[7]Hernandez L,Pajares JA,Menchen P.Duodenopancreatic fistula complicating upper gastrointestinal Crohn's disease: successful treatment with infliximab.[J].2009,104(7).
[8]Jung, Yoon Suk,Han, Minkyung,Park, Sohee,etc.Cancer Risk in the Early Stages of Inflammatory Bowel Disease in Korean Patients: A Nationwide Population-based Study[J].2017,11(8).
[9]Fotios S,Fousekis,Vasileios I,Theopistos,Konstantinos H,Katsanos,etc.Pancreatic Involvement in Inflammatory Bowel Disease: A Review.[J].2018,10(10).
[10]W P, BALL,A H, BAGGENSTOSS,J A, BARGEN.Pancreatic lesions associated with chronic ulcerative colitis.[J].1950,50(3).
[11]Nilesh, Chande,David J, Tsoulis,John K, MacDonald.Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease.[J].2013,4.
[12]Schoepfer, Alain,Rogler, Gerhard,Scharl, Michael,etc.Extraintestinal Manifestations of Inflammatory Bowel Disease[J].2015,21(8).
[13]Ying-Chao, Li,Wei-Zhi, Li,Chang-Rui, Wu,etc.Prevalence and characteristics of ophthalmological extra-intestinal manifestations in Chinese patients with inflammatory bowel disease.[J].2016,(10).
[14]Rasmussen HH,Fonager K,Sorensen HT,etc.Risk of acute pancreatitis in patients with chronic inflammatory bowel disease. A Danish 16-year nationwide follow-up study.[J].1999,34(2).
[15]Harbord, Marcus,Annese, Vito,Vavricka, Stephan R.,etc.The First European Evidence-based Consensus on Extra-intestinal Manifestations in Inflammatory Bowel Disease[J].2016,10(3).
[16]Drabik, Attyla,Stallmach, Andreas,Buendgens, Burkhard,etc.Azathioprine-induced Acute Pancreatitis in Patients with Inflammatory Bowel Diseases-A Prospective Study on Incidence and Severity[J].2016,10(1).
[17]Javier, Martín-de-Carpi,Melinda, Moriczi,Gemma, Pujol-Muncunill,etc.Pancreatic Involvement in Pediatric Inflammatory Bowel Disease.[J].2017,5(Spec ).
[18]Pitchumoni CS,Das K,Rubin A.Pancreatitis in inflammatory bowel diseases.[J].2010,44(4).
[19]Bermejo F,Algaba A,Taxonera C,etc.Acute pancreatitis in inflammatory bowel disease, with special reference to azathioprine-induced pancreatitis.[J].2008,28(5).
[20]L E, CHAPIN,H H, SCUDAMORE,A H, BAGGENSTOSS,etc.Regional enteritis: associated visceral changes.[J].1956,30(3).
[21]Alexander, Schneider,Michael, Hirth,Christel, Weiss,etc.Prevalence of inflammatory bowel disease in alcoholic, non-alcoholic and autoimmune pancreatitis.[J].2018,56(5).
[22]K L, Isaacs,D, Murphy.Pancreatitis after rectal administration of 5-aminosalicylic acid.[J].1990,12(2).
[23]B Al-Judaibi,U I Schwarz,N Huda,etc.Genetic Predictors of Azathioprine Toxicity and Clinical Response in Patients with Inflammatory Bowel Disease.[J].2016,23(1).
[24]Diane Lorenzo,Frédérique Maire,Carmen Stefanescu,etc.Features of Autoimmune Pancreatitis Associated With Inflammatory Bowel Diseases[J].2018,16(1).
[25]Li-Hua, Dong,Zhong-Min, Liu,Shi-Ji, Wang,etc.Corticosteroid therapy for severe acute pancreatitis: a meta-analysis of randomized, controlled trials.[J].2015,8(7).
[26]J, Faintuch,C B, Mott,M C, Machado.Pancreatitis and pancreatic necrosis during sulfasalazine therapy.[J].1900,70(3).
[27]Day, Andrew S.,Lemberg, Daniel A.,Ledder, Oren.Thiopurine-induced pancreatitis in inflammatory bowel diseases[J].2015,9(4).
[28]Stobaugh,D.J.,Deepak,P..Effect of Tumor Necrosis Factor-α Inhibitors on Drug-Induced Pancreatitis in Inflammatory Bowel Disease[J].2014,48(10).
[29]Filippo, Antonini,Raffaele, Pezzilli,Lucia, Angelelli,etc.Pancreatic disorders in inflammatory bowel disease.[J].2016.
[30]Fabrizio Parente,Luca Pastore,Stefano Bargiggia,etc.Incidence and risk factors for gallstones in patients with inflammatory bowel disease: A large case-control study[J].2007,45(5).